Zoetis reported $2.54B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Align Technology USD 212.24M 2.7M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Charles River Laboratories USD 319.64M 26.62M Sep/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Dentsply International USD 707M 42M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Henry Schein USD 2.05B 9M Sep/2026
Idexx Laboratories USD 390.87M 705K Sep/2026
Illumina USD 667M 38M Sep/2026
J&J USD 15.38B 233M Sep/2026
Laboratory Of America USD 538.4M 23.8M Sep/2026
Merck USD 6.16B 43M Sep/2026
Neogen USD 144.3M 17.4M Mar/2026
Pacira USD 3.83B 3.69B Sep/2026
Perrigo USD 1.01B 50.7M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Phibro Animal Health USD 567.14M 32.26M Sep/2026
Quest Diagnostics USD 218M 15M Sep/2026
Sanofi EUR 24.12B 620M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Zoetis USD 2.54B 38M Sep/2026